Bullish Case: 23andMe's recent partnership extension with GSK, which involves a $20 million upfront payment and potential for downstream royalties, could provide an ongoing revenue source [ksby.com, krtv.com]. Additionally, the positive data update of the Phase 1/2a clinical trial bolsters the potential of 23andMe's biopharmaceutical operations [biospace.com].


Show historical bullish cases

Bearish Case: The recent report of a massive data breach involving sensitive customer records may damage 23andMe's reputation, negatively impacting customer trust and potentially leading to decreased sales [ctnewsjunkie.com, wlos.com].


Show historical bearish cases

Takeaway: While 23andMe's robust partnership with GSK and positive clinical trial results enhance the company's revenue prospects, the data breach may pose substantial reputational and regulatory risks.


Show historical takeaways

Potential Outcomes:

1. Regulatory measures (45%): Investigations related to the data breach may lead to regulatory measures and fines, affecting profitability [wlos.com].

2. Positive clinical trial results (30%): If further trials of 23ME-00610 continue to yield positive results, this could significantly boost the company's stock [biospace.com].

3. Negative public sentiment (60%): If public sentiment worsens post-breach, this could result in a significant decline in sign-ups and increased customer churn [wlos.com].

4. Increased collaboration with pharmaceutical companies (25%): The company's data collaboration with GSK might attract further partnerships with other pharmaceutical companies, boosting revenue [krtv.com].


November 24, 2023


23andMe Forecast

[ME]  23andMe
Price Forecast: BEARISH    Price Action: RANDOM (?)



Make More Profitable Trades with ME Forecasts + Trading Strategies







ME Balanced News:












Become a more profitable trader with AI optimized trading strategies




Correlated Stock Forecasts

Assets that tend to move strongly with ME



ETSY Forecast + Options Trading Strategies   [ETSY]  Etsy (0.94)


AA Forecast + Options Trading Strategies   [AA]  Alcoa (0.94)


PSEC Forecast + Options Trading Strategies   [PSEC]  Prospect (0.94)


WPC Forecast + Options Trading Strategies   [WPC]  W. P. Carey (0.94)


UNFI Forecast + Options Trading Strategies   [UNFI]  United Natural Foods (0.94)



Uncorrelated Stock Forecasts

Assets with little price relationship to ME



KTB Forecast + Options Trading Strategies   [KTB]  Kontoor Brands (0.01)


VGK Forecast + Options Trading Strategies   [VGK]  Vanguard FTSE Europe (-0.01)


SITM Forecast + Options Trading Strategies   [SITM]  SiTime (0.01)


SU Forecast + Options Trading Strategies   [SU]  Suncor Energy (-0.02)


AIG Forecast + Options Trading Strategies   [AIG]  American International (0.02)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against ME



TDW Forecast + Options Trading Strategies   [TDW]  Tidewater Inc. - New (-0.85)


SKYW Forecast + Options Trading Strategies   [SKYW]  Skywest (-0.85)


DXJ Forecast + Options Trading Strategies   [DXJ]  WisdomTree Japan Hedged Equity (-0.88)


SPOK Forecast + Options Trading Strategies   [SPOK]  Spok (-0.91)


RELY Forecast + Options Trading Strategies   [RELY]  Remitly (-0.91)